Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Melanoma
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Melanoma
    TopAbstracts in Melanoma 10/21/2009 - (DGNews)
    TopAbstracts in Melanoma 09/23/2009 - (DGNews)
    Study Reveals New Genetic Mutations Involved in Melanoma - (DGNews)
    TopAbstracts in Melanoma 08/26/2009 - (DGNews)
    Budesonide Fails as Diarrhoea Prophylactic in Melanoma Patients Receiving Ipilimumab - (DGNews)

    News archive

     Recent webcasts/CME - Melanoma
    • Moving Beyond Standard Therapy in Malignant Melanoma: Novel Agents and Combinations
    • Adjuvant Interferon Therapy Prolongs Relapse-Free Interval and Survival in Melanoma
    • Rational Vaccine Strategies May Better Harness the Immune System for Anticancer Response in Melanoma
    • Response May Not Be an Appropriate Endpoint for Evaluating Benefit From CTLA-4 Antagonists in Melanoma
    • Emerging Strategies for the Treatment of Metastatic Melanoma: The Role of Monoclonal Antibodies in Targeted Immunotherapy

      Webcasts/CME archive

       Recent cases - Melanoma
        Diffuse Anorectal Melanoma; Review of the Current Diagnostic and Treatment Aspects Based on a Case Report
        Malignant Melanoma Associated with a Blue Naevus: A Case Report
        Metastatic Malignant Melanoma of the Conjunctiva: A Case Report
        Delayed Malignant Melanoma Recurrence Simulating Primary Ovarian Cancer
        A 90-Year-Old Woman with an Asymptomatic Spot on Her Cheek

        Cases archive
          




        my personal edition > melanoma > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Biopsy Accuracy Varies For Invasive Cutaneous Melanoma

        A DGReview of :"Evaluating invasive cutaneous melanoma: Is the initial biopsy representative of the final depth?"
        Journal of the American Academy of Dermatology

        03/25/2003
        By Anne MacLennan


        Deep shave biopsies are preferable to superficial shave or punch biopsies for thin and intermediate depth melanomas when initial samples are taken for diagnosis instead of complete excision.

        Researchers in the United States make this suggestion following a retrospective evaluation of the accuracy of preliminary biopsies of 145 cases of invasive cutaneous melanoma.

        Dr P C Ng and colleagues from the Case Western Reserve University/University Hospitals of Cleveland, Ohio, used biopsies done by 72 dermatologists. Forty six of the dermatologists were highly experienced.

        An accurate initial biopsy of the deepest portion of a melanoma is vital to the management of patients with these tumours. To determine if initial biopsy was representative of the final depth of the tumour in these cases, these investigators compared Breslow depth on preliminary biopsy with Breslow depth on subsequent excision.

        Overall, 88% of non-excisional initial shave and punch biopsies in the 145 study cases were accurate, with Breslow depth greater than or equal to subsequent excision Breslow depth.

        Both superficial and deep shave biopsies were more accurate than was punch biopsy for melanomas of less than 1 mm.

        Overall, excisional biopsy was found to be the most accurate, these investigators report.
        J Am Acad Dermatol 2003 Mar;48:3:420-4. "Evaluating invasive cutaneous melanoma: Is the initial biopsy representative of the final depth?"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send